2014
DOI: 10.2174/0929867321666140815124246
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

Abstract: Nanomedicine has recently emerged as an exciting tool able to improve the early diagnosis and treatment of a variety of intractable or age-related brain disorders. The most relevant properties of nanomaterials are that they can be engineered in such a way that they can cross the blood brain barrier, with the final aim of targeting specific cells and molecules and to act as vehicles for drugs. Potentially beneficial properties of nanotherapeutics derived from its unique characteristics include improved efficacy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(15 citation statements)
references
References 309 publications
(180 reference statements)
0
15
0
Order By: Relevance
“…The direct or invasive techniques include surgical methods to administer drugs directly into the brain and the disruption of the BBB to open it. Meanwhile, the indirect or noninvasive techniques include nonaggressive approaches to access the brain without affecting this barrier integrity [ 11 , 12 ]. These noninvasive techniques include alternative systemic administration routes like intranasal administration [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The direct or invasive techniques include surgical methods to administer drugs directly into the brain and the disruption of the BBB to open it. Meanwhile, the indirect or noninvasive techniques include nonaggressive approaches to access the brain without affecting this barrier integrity [ 11 , 12 ]. These noninvasive techniques include alternative systemic administration routes like intranasal administration [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…NPs are highly stable 3D encapsulation systems that can be loaded with drugs and functionalized with targeting ligands or antibodies, and they can be used as nanocarriers to deliver drugs to the CNS [ 20 ]. Among other materials, natural or synthetic polymers and lipids have been employed in NP development [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Nanomaterials are usually characterized by unique optical, electronic or mechanical properties, and are nowadays increasingly used in a multitude of applications such as medical (Ghosh et al, 2008; Chen et al, 2013; Oyefusi et al, 2014; Simões et al, 2015), cosmetic (Borowska and Brzóska, 2015; Patil et al, 2015), electronics (Kang et al, 2015; Zhou and Guo, 2015), machine engineering, and construction industry (Hincapié et al, 2015) or in the environmental field (Carpenter et al, 2015; Sharma et al, 2015). Due to their small size and advancements in synthesis methods, nanomaterials have many advantageous traits, such as high surface area-to-volume ratio, multi-functionality, site-specific delivery or targeting, controlled release, and versatility in enabling surface modification (Garbayo et al, 2014; Kumar et al, 2017). Therefore, nanomaterials can be used as vectors for drug delivery, as strategies for neuroprotection, as scaffolds for neuroregeneration, as modalities for neuroimaging and as devices for neurosurgery (Gilmore et al, 2008; Kumar et al, 2017).…”
Section: Nanomaterialsmentioning
confidence: 99%
“…Lack of reliable technology to scale up the production of advanced nanomaterials [90], 2) Considerable regulatory hurdles and market forces [90,91], 3) lower profit margins for imaging than for therapeutic drugs [90] …”
Section: X-ray Computed Tomographymentioning
confidence: 99%
“…Nowadays, nanomedicine theranostics for cancer is progressing with the design of multifunctional platforms that consist of colloidal NP ranging in sizes from 10 to 1000 nm in which the diagnostic and therapeutic agents are adsorbed, conjugated, entrapped or encapsulated [91,93]. The same therapeutic agent has not the same effect on all patients with the same diagnosis.…”
Section: Cancer Theranostics and Nanotechnologymentioning
confidence: 99%